Skip to content

LGND

Ligand Pharmaceuticals Incorporated

Stock

$302.96+0.22 (+0.07%)Close Oct 2, 2026

Diluted EPS, 2025
$6.13
10-year CAGR
−5.5%

Diluted EPS

Diluted EPS by fiscal year

PeriodEPSYoY
2025$6.13—
2024−$0.22—
2023$2.94—
2022−$1.98—
2021$3.31—
2020−$0.18—
2019$31.85+434.4%
2018$5.96+1,024.5%
2017$0.53—
2016−$0.08—
2015$10.83+1,833.9%
2014$0.56+1.8%
2013$0.55—
2012−$0.03—
2011$0.49—
2010−$0.53—
2009−$0.10—